John Persinos is the editorial director of Investing Daily, overseeing such publications as Personal Finance, Utility Forecaster, Profit Catalyst Alert, Rapier's Income Accelerator, Income Forecaster, and Marijuana Investing Daily, among others. John also writes the Mind Over Markets daily stock market recap, and he's the chief investment strategist of Marijuana Profit Alert.
John has decades of experience in the technology and political realms. He has worked as a staff editor at Inc. and Venture magazines, and written for Kiplinger's, Street Authority, Investing Answers, and TheStreet.com, to name a few. In a career that has spanned more than 40 years, John has been diligently and prolifically covering the news and its impact on investors.
John also has experience with the inner-workings of Capitol Hill, serving as a press secretary to U.S. Rep. Byron Dorgan (D-ND). John started his career as a daily newspaperman with The Orlando Sentinel.
John holds undergraduate and graduate degrees from Boston University. He also completed the Davenport Fellowship in Business and Economics Reporting at the University of Missouri (Columbia).
Analyst Articles
Discover in an authoritative guide how 16-year-olds can invest in stocks through custodial accounts and acquire financial skills for success in the future. Read More
Discover in an authoritative guide how 16-year-olds can invest in stocks through custodial accounts and acquire financial skills for success in the future. Read More
The latest PCE data showed moderating inflation, boosting the odds of lower interest rates. Here are the equity sectors you should consider. Read More
The latest PCE data showed moderating inflation, boosting the odds of lower interest rates. Here are the equity sectors you should consider. Read More
A New Dawn For The World Of Crypto
June 3, 2024
Research into LSD, psilocybin, and other psychedelics is accelerating, as biotech firms race to develop new drugs based on these substances. Read More
Research into LSD, psilocybin, and other psychedelics is accelerating, as biotech firms race to develop new drugs based on these substances. Read More
Editor’s Note: Happy Friday, dear reader! I am headed out today to do some camping with my daughter’s Girl Scout troop. Please keep me in your thoughts during this difficult time. ConocoPhillips to Acquire Marathon Oil Yesterday, ConocoPhillips (NYSE: COP) announced it had… Read More
Debunking “Sell in May and Go Away”
May 31, 2024
Here’s why rigidly following the sell in May strategy could lead to missed opportunities. This month, for example, has been great for stocks. Read More
Here’s why rigidly following the sell in May strategy could lead to missed opportunities. This month, for example, has been great for stocks. Read More
Wall Street Continues to Wait for Godot
May 30, 2024